Evercore ISI cuts Booking Holdings stock price target on caution

Evercore ISI cut Booking Holdings’ price target sharply to $250 from $6,250 while keeping an Outperform rating, but still expects a modest Q1 beat with bookings of $53.9B (+16% YoY) and revenue of $5.5B (+12% YoY). The firm sounded more cautious on the second half and flagged downside variance risk due to Middle East exposure and dependence on Europe and Asia-Pacific, though it expects management to reaffirm high-single-digit growth guidance. Recent analyst moves remain mixed, with several firms still positive on BKNG despite the target reset.

Analysis

The market is treating this as a clean “quality growth at a discount” setup, but the real issue is not valuation — it is dispersion. BKNG’s revenue mix makes it a macro proxy for Europe and Asia-Pacific travel demand, so the next leg of the stock will likely be driven less by headline quarter prints and more by whether management sounds comfortable with second-half demand durability. That means the stock can still trade well on a modest beat, but the upside is probably capped unless the company can show booking acceleration outside the U.S. and evidence that Middle East spillover is not leaking into broader leisure demand.

The deeper second-order effect is on competitors with more domestic exposure. If BKNG signals caution while still holding growth guidance, it implicitly reinforces that the public travel demand pool is bifurcating: international-heavy OTAs are more vulnerable to regional shocks, while U.S.-centric hotel, airline, and leisure names may be relatively insulated and attract rotation capital. That creates a relative-value opportunity even if the absolute travel tape stays constructive.

The downside catalyst is not a single quarter miss; it is guidance language. If management turns incrementally cautious on H2, the multiple can compress quickly because the stock has been rerated on the assumption that travel is still a clean post-pandemic comp story. The contrarian read is that consensus may be underestimating estimate revision risk: the stock can look cheap on next-twelve-month earnings, but if analysts are already trimming, the more important variable is whether FY26 EPS growth stays in the mid-teens or decelerates into the low double digits, which would justify a lower multiple than the market is likely assigning today.

Key Decisions for Investors

• Avoid chasing BKNG into earnings; prefer to wait for the print and buy only on an initial post-earnings selloff if management confirms guide instead of cutting it. Risk/reward is better on a 5-8% pullback than ahead of a binary commentary event.
• Relative-value pair: long BKNG / short a more U.S.-exposed travel beneficiary only if BKNG holds guidance; otherwise invert the pair and rotate to domestic leisure/hotel names. The key is the geographic mix differential, not the headline travel beta.
• Initiate a short-dated BKNG call spread hedge against the event if already long the name: buy a near-the-money call and sell a 10-15% OTM call into earnings to capture upside from a modest beat while limiting downside from cautious H2 commentary.
• Watch analyst estimate revisions over the next 2-4 weeks; if downward revisions continue and the stock stays elevated, consider a tactical short ahead of guidance-driven multiple compression. The setup is most attractive if the market is pricing in a beat but not a tone shift.
• On any evidence that Europe/APAC booking growth is stabilizing, use BKNG as a high-quality travel recovery proxy; if not, favor lower-volatility domestic leisure names over BKNG for exposure to the sector.